Lucid Diligence Brief: SiranBio and GSK SA030 Licensing Agreement
Lucid Diligence Brief: SiranBio and GSK SA030 Licensing Agreement Professional…
Obesity Today—May 5, 2026
This week’s Obesity update highlights clinical progress, pipeline expansion,…
Endocrinology Today—April 28, 2026
This week’s Endocrinology update highlights regulatory actions, clinical…
Obesity Today—April 21, 2026
This week’s Obesity update highlights regulatory follow-up, oral treatment…
Endocrinology Today—April 14, 2026
This week’s Endocrinology update highlights regulatory clearances, commercial…
Obesity Today—April 14, 2026
This week’s Obesity update highlights regulatory and commercial momentum,…
Obesity Today—April 7, 2026
This week’s Obesity update highlights regulatory progress, advancing late-stage…
AI in Healthcare and Digital Health Today—April 6, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1 asset
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1……
Obesity Today—March 31, 2026
This week’s Obesity update highlights regulatory progress, advancing late-stage…
Obesity Today—March 24, 2026
This week’s Obesity update highlights regulatory progress, advancing clinical…
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly…